InvestorsHub Logo
Followers 12
Posts 765
Boards Moderated 1
Alias Born 01/09/2017

Re: None

Saturday, 08/11/2018 9:41:37 AM

Saturday, August 11, 2018 9:41:37 AM

Post# of 48252
SOME DD on Therakine


Therakine have a legit, sustaining delivery method here that could or is already bringing in millions of revenue. Especially if they tie it to cannabis and could already have the products developed for the medical cannabis industry. I think they're keeping that hush at the moment as their website is down.

Remember at only a 50mm marketcap puts this at $.04 but I think we're headed higher.

These are some of the companies our IR company represents.
MariMed Inc $511 Million
Marijuana Company of America $66 Million
SQL Technologies Corp $160 Million
Kaya Holdings $20 Million



Mr. Yakatan: In simple forms, we
figured out a way to take an existing
drug and extend its life, whether it is
hydrophobic or hydrophilic. We can
then place, for example, a six months
supply of the drug directly into the
body and have it released exactly
when it needs to be.
What is unique is
that we use physics, instead of modifying
the drug chemically: we mechanically
form biopolymers or biopolymer
derivatives using only already
approved additives. Then we
modify those carefully under controlled
conditions. Then we create a
number of cycles of pressing and
kneading that transform the mixture
of ingredients into a polymer elastic
body of high stability.


Here is info about Therakine licencing their delivery method for Naltrexone to BicxCorp (52 week high of .$28) with an estimsted demand of $185 million in 2016.

https://ir.biocorrx.com/press-releases/detail/59/biocorrx-announces-license-agreement-with-therakine-ltd-to

Another licensing deal:
https://finance.yahoo.com/news/therakine-cell-care-therapeutics-engage-125051964.html











Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.